Orviva

Learn · Pharmacogenomics · NAT2

Hydralazine and NAT2

Hydralazine is cleared by NAT2. Slow acetylators have higher exposure and a much higher rate of drug-induced lupus with prolonged use.

Antihypertensive (vasodilator) CPIC level A · Source: CPIC 2025 (PMID: 40974042)

Why does NAT2 matter for Hydralazine?

Hydralazine is cleared by NAT2. Slow acetylators have higher exposure and a much higher rate of drug-induced lupus with prolonged use. NAT2 inactivates drugs by acetylation. Its common haplotypes split people into rapid, intermediate and slow acetylators, and the split is strongly population-dependent: about half of Europeans and South Asians are slow acetylators, against roughly one in ten East Asians. Slow acetylators clear isoniazid, hydralazine, sulfasalazine, dapsone and procainamide more slowly and are more prone to their toxicities, from isoniazid liver injury to hydralazine-induced lupus.

What does CPIC recommend for each NAT2 phenotype on Hydralazine?

The guidance below is the CPIC recommendation for prescribers, reproduced for reference. It is written for a clinician who knows the whole picture — never start, stop or change a medicine on the basis of this page.

PhenotypeCPIC-based guidance
Rapid AcetylatorStandard dose titration. May require higher doses for blood pressure control due to faster drug metabolism.
Intermediate AcetylatorStandard dose titration with routine monitoring.
Slow AcetylatorUse with caution. Slow acetylators have significantly higher risk of drug-induced lupus erythematosus (DILE), especially with prolonged use or high doses. Consider alternative antihypertensives if possible. If used, monitor for lupus symptoms (joint pain, rash, serositis) and check ANA periodically.

Evidence level A · CPIC 2025 (PMID: 40974042). Phenotype definitions: NAT2 metaboliser phenotypes.

Which NAT2 alleles decide the phenotype?

The phenotype is read from the two NAT2 star alleles a person carries. The full allele table, with the defining variants and their population frequencies, is on the NAT2 gene page.

NAT2 haplotypes are inferred from a panel of seven coding SNPs; consumer chips usually carry the four that define the common slow alleles (rs1801279, rs1801280, rs1799930, rs1799931). Phase — which variants sit on the same chromosome — is not observed directly, so the diplotype is a statistical inference.

Other drugs affected by NAT2

Check your NAT2 type before your next Hydralazine conversation with a prescriber
Upload your raw DNA file and see your metaboliser status → · Ask G2: “Does my NAT2 genotype affect Hydralazine?”

Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.